I don't have any position in the stock, so not sure how I'd be kicked in the teeth. This company is going broke. They have nothing in the bank. They will try to do another offering and will probably get it done, but still, with a few hundred scripts they're not going to make any money. They have a worthless schizo drug and a worthless sleep drug. Good luck buddy.
Hope you have good dental insurance. You will need it soon when you get kicked in the head as the stock runs up to $15+
completely agree which is why I am out for now. Mgmt has been terrible with communicating goals and objectives since the FDA approval process came to an end and has done little to issue PR's to let investors know how the drug is doing in the U.S. or how the timetable looks from an EU standpoint.
Man, I cannot stand how many times people come up with the "buyout" #$%$. I was right about this pos a half year ago and am right now. This company is going broke and will be out of business within 1 year. No cash, very little sales and very little chance of growth. They'll try to raise more cash, but questionable if they get it done. Good luck.
Not sure about selling the company but can Management at least let us know what is going on? As an example Hetlioz is currently with the EMA being evaluated for the European market - what is going on lads - where are we? Are you in touch with the EMA? Some say management are not in control - let us know what you are doing as the share price collapses. Staying silent is not the answer.
with 40% of the float being short, how much of that is hedging a long position? no one knows, but it can't be more than 40% of the float,,,,lol
but really, you shouldn't use the word "management" to describe the stooges. this co should have been sold when they had $200,000,000 in cash and newly approved drug with nda, which wasn't that long ago. the only thing they are good for is self-preservation and job security.
Sentiment: Strong Sell
I emailed management about the current state of these phase trials and received a response that VLY 686, which is a drug that has shown the ability to reduce the urge to drink in alcoholics, is due to complete phase II and have data released by mid 2015. This is encouraging and will tell whether this has the potential to be a blockboster in a patient pool that is very large and at present has little in the way of drug options for this disease.
Or maybe 11. Anyways it's around there. You can easily see on a chart the stock has continuously come to that area over the last 15 months and even back in 2009-2010 the stock hung around there like crazy.
really just not enough good news to thrill anyone, cash burn rate and profitability, they are starting to look like more of a buy out candidate,i in at 8 to 9
Sentiment: Strong Sell
I can't disagree more. If all 400 is filled, they will be raking in $32 million a year based on WAC cost VNDA announced in June. Keep in mind this is just 3 months of sales. If this pace continues, that translated to over $120 million of sales a year. For a $500 million market cap company, this is huge. I just loaded some more. Just my opinion.
Sentiment: Strong Buy
Bad. Why? 400 or so scripts? C'mon. 400? Sure, it's fairly early, but they've pounded the radio for months and all they have managed is 400 scripts? They're going to burn through all of their cash by year end. Then what? Another offering. More dilution. Good luck to all who own this stock. You're going to need it.